Stock Monitor: Achillion Pharma Post Earnings Reporting

LONDON, UK / ACCESSWIRE / February 27, 2018 / Active-Investors.com has just released a free research report on Bellicum Pharma, Inc. (NASDAQ: BLCM). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=BLCM as the Company’s latest news hit the wire. On February 23, 2018, the Company, which is a clinical stage biopharmaceutical organization that works towards discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders, shared an update on the clinical hold of US studies for its CAR-T candidate BPX-501. Register today and get access to over 1000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is currently working on the research report for Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN), which also belongs to the Healthcare sector as the Company Bellicum Pharma. Do not miss out and become a member today for free to access this upcoming report at:

www.active-investors.com/registration-sg/?symbol=ACHN

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Bellicum Pharma most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=BLCM

Bellicum shared that it has received a notification from the US Food and Drug Administration (FDA) which outlines the criteria required for lifting the clinical hold imposed on US studies of BPX-501.

About BPX-501

Bellicum’s lead product candidate, BPX-501, has been specifically designed to improve outcomes for patients undergoing haplo-identical (i.e. partial match) hematopoietic stem cell transplants (HSCT). BPX-501 is an adjunct T cell therapy administered after HSCT. It comprises genetically modified donor T cells, based on Bellicum’s CaspaCIDe® safety switch.

The use of BPX-501 provides the patient with the benefit of having T cells to fight infection, support engraftment, and prevent disease relapse. In case graft versus host disease (GvHD) occurs, the CaspaCIDe® safety switch can be activated to kill the toxic T cells. Thus, BPX-501 can improve outcomes and extend patient eligibility for a haplo-transplant. It also allows physicians to perform stem cell transplants more safely.

Clinical Hold on BPX-501 Studies Due to Encephalopathy Cases

Bellicum received a notice from the FDA to put a clinical hold on the US studies of BPX-501 on January 30, 2018. The agency suspended all studies after three cases of encephalopathy related to BPX-501 were reported.

However, it should be noted that the clinical hold does not affect the Company’s BP-004 registration trial in Europe.

Bellicum’s Plan of Action

Since the clinical hold was imposed last month, the Company had been waiting for a formal communication from the FDA to determine the requirements for resuming studies. Now that the FDA has outlined the criteria, Bellicum will work closely with the agency to address their requirements.
Bellicum intends to implement revisions to the US study protocols, such as the addition of more comprehensive monitoring and management of neurotoxicity.
Moreover, the Company plans to revise the Investigator Brochure and Informed Consent Documents to notify healthcare providers, patients, and caregivers of the changes.
The Company intends to provide a full response to the FDA with respect to these issues within a few weeks.

Improved Investor Sentiment

Bellicum’s investors are waiting for the clinical hold to be lifted. The FDA’s guidelines allow the Company to prepare a plan of action for obtaining the regulatory approval for BP-004.

Thus, the announcement about the FDA’s notification went well with the investors. On the day of the announcement, shares were up 33% since bottoming at $5.02 on January 31, 2018, due to the news of clinical hold.

Stock Performance Snapshot

February 26, 2018 – At Monday’s closing bell, Bellicum Pharma’s stock rose 3.56%, ending the trading session at $7.28.

Volume traded for the day: 672.02 thousand shares.

After yesterday’s close, Bellicum Pharma’s market cap was at $229.68 million.

The stock is part of the Healthcare sector, categorized under the Biotechnology industry. This sector was up 1.0% at the end of the session.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com
Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 490845

Stock Monitor: FTI Consulting Post Earnings Reporting

LONDON, UK / ACCESSWIRE / February 27, 2018 / Active-Investors.com has just released a free earnings report on Booz Allen Hamilton Holding Corp. (NYSE: BAH) (“Booz Allen”). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=BAH. The Company posted its financial results on February 05, 2018, for the third quarter of the fiscal year 2018 (Q3 FY18). The Company’s adjusted diluted earnings per share (EPS) grew 26.3% on a y-o-y basis, beating market consensus expectations. Register today and get access to over 1000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is currently working on the research report for FTI Consulting, Inc. (NYSE: FCN), which also belongs to the Services sector as the Company Booz Allen Hamilton Holding. Do not miss out and become a member today for free to access this upcoming report at:

www.active-investors.com/registration-sg/?symbol=FCN

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Booz Allen Hamilton Holding most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=BAH

Earnings Highlights and Summary

For the three months ended December 31, 2017, Booz Allen reported revenues of $1.50 billion, rising 6.8% from the $1.40 billion recorded at the end of Q3 FY17. However, the Company’s GAAP net revenue numbers fell short of market expectations of $1.52 billion. Furthermore, the Company’s revenues, excluding billable expenses, rose 8.3% to $1.06 billion in Q3 FY18 from $975.95 million in Q3 FY17.

The defense contractor recorded a net income of $69.77 million, or $0.47 per diluted share, in Q3 FY18 compared to $55.59 million, or $0.37 per diluted share, in Q3 FY17. The Company’s adjusted net income grew to $70.25 million, or $0.48 per diluted share, during Q3 FY18 from $56.63 million, or $0.38 per diluted share, in Q3 FY17. Meanwhile, Wall Street had expected Booz Allen to report an adjusted net income of $0.43 per diluted share for Q3 FY18.

Operating Metrics

In the three months ended December 31, 2017, the Company spent $712.26 million on cost of revenues, up from $652.24 million in the prior year’s same quarter. The Company incurred billable expenses of $443.02 million in Q3 FY18 compared to $428.69 million in Q3 FY17. The Company’s general and administrative expenses came in at $209.86 million versus $201.18 million in Q3 FY17. The Company’s total operating costs and expenses came in at $1.38 billion during Q3 FY18, up from $1.30 billion in Q3 FY17.

The McLean, Virginia-based Company’s adjusted operating income increased to $118.09 million during Q3 FY18 from $109.18 million in the previous year’s comparable quarter. Furthermore, the Company reported adjusted earnings before interest, tax, depreciation, and amortization (EBITDA) of $134.79 million, or 9.0% of revenues, in Q3 FY18 versus $122.53 million, or 8.7% of revenues, in Q3 FY17.

Cash Flow and Balance Sheet

During the three months ended December 31, 2017, Booz Allen generated $68.86 million in cash from operating activities, up from $65.96 million in the third quarter of the fiscal year 2017. However, the Company’s free cash flow fell to $42.78 million in Q3 FY18 from $50.55 million in Q3 FY17.

Booz Allen had cash and cash equivalents of $289.50 million as on December 31, 2017, compared to $217.42 million as on March 31, 2017. Furthermore, the Company’s long-term debt increased to $1.77 billion as on December 31, 2017, from $1.47 billion as on March 31, 2017.

Dividend and Share Repurchase

In its quarterly earnings report, the Company’s Board of Directors announced a 12% increase in quarterly cash dividend to $0.19 per share. The dividend will be paid on February 28, 2018, to stockholders of record as on February 14, 2018.

During Q3 FY18, the Company paid dividends of approximately $25 million and has repurchased approximately 833 thousand shares. Additionally, in the first three quarters of FY18, the Company has returned $275 million in the form of regular dividends and share repurchases.

Outlook

In its guidance for the full year FY18, Booz Allen expects revenue growth to be in the range of 5.5% to 7.5%, and adjusted diluted EPS is projected to be between $1.87 and $1.95.

Stock Performance Snapshot

February 26, 2018 – At Monday’s closing bell, Booz Allen Hamilton Holding’s stock marginally rose 0.78%, ending the trading session at $38.80.

Volume traded for the day: 662.79 thousand shares.

Stock performance in the last three-month – up 3.60%; previous six-month period – up 14.12%; past twelve-month period – up 8.02%; and year-to-date – up 1.76%

After yesterday’s close, Booz Allen Hamilton Holding’s market cap was at $5.56 billion.

Price to Earnings (P/E) ratio was at 20.20.

The stock has a dividend yield of 1.96%.

The stock is part of the Services sector, categorized under the Management Services industry. This sector was up 0.7% at the end of the session.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com
Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 490846

Stock Monitor: Momenta Pharma Post Earnings Reporting

LONDON, UK / ACCESSWIRE / February 27, 2018 / Active-Investors.com has just released a free earnings report on Catalent, Inc. (NYSE: CTLT).If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=CTLT. The Company reported its second quarter fiscal 2018 operating and financial results on February 05, 2018. The maker of drug delivery technologies outperformed top- and bottom-line expectations, and also announced the appointment of a new Chief Financial Officer (CFO). Register today and get access to over 1000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is currently working on the research report for Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA), which also belongs to the Healthcare sector as the Company Catalent. Do not miss out and become a member today for free to access this upcoming report at:

www.active-investors.com/registration-sg/?symbol=MNTA

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Catalent most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=CTLT

Earnings Highlights and Summary

During Q2 FY18, Catalent reported revenues of $606.3 million, reflecting an increase of 25% on an as reported basis, and 22% in constant currency, from $483.7 million in Q2 FY17. The Company’s revenue numbers topped analysts’ estimates of $568.3 million.

During Q2 FY18, Catalent’s gross margin increased 50 basis points to 31.1% from 30.6% in Q2 FY17, which was primarily attributable to a favorable product mix within the Drug Delivery Solutions segment, and the Cook Pharmica acquisition. For the reported quarter, the Company’s selling, general, and administrative expenses (SG&A) were $114.3 million and represented 18.9% of revenues compared to $96.2 million, or 19.9% of revenues, in the prior year’s same quarter.

For Q2 FY18, Catalent’s net loss was $21.9 million, or $0.16 loss per diluted share, compared to net earnings of $17.4 million, or $0.14 per diluted share, in Q2 FY17. During the reported quarter, the Company recorded a one-time net tax charge of $46.0 million as a provisional estimate of the net accounting impact of the recently enacted US Tax Cuts and Jobs Act 2017 (TCJA). For Q2 FY18, Catalent’s adjusted earnings were $60.7 million, or $0.45 per diluted share, compared to $34.7 million, or $0.27 per diluted share, in the prior year’s comparable quarter; beating Wall Street’s estimates of $0.34 per share.

During Q2 FY18, Catalent’s earnings before interest, tax, depreciation, and amortization (EBITDA) from continuing operations increased 20% to $102.0 million from $85.2 million in Q2 FY17. The Company’s adjusted EBITDA was $139.3 million, or 23.0% of revenues, in the reported quarter compared to $98.1 million, or 20.3% of revenues, in the prior year’s corresponding quarter.

Business Segment Results

During Q2 FY18, Catalent’s Softgel Technologies segment’s revenues jumped 13%, or 9% on constant currency, to $228.1 million compared to $201.9 million in Q2 FY17. The constant-currency growth was attributable to the Accucaps acquisition in February 2017. The segment’s EBITDA increased 15% to $50.1 million in Q2 FY18 versus $43.1 million in Q2 FY17, primarily driven by the acquisition of Accucaps.

For Q2 FY18, Catalent’s Drug Delivery Solutions segment’s revenues surged 33%, or 30% on constant currency, to $285.4 million compared to $214.0 million in Q2 FY17. The growth was primarily attributable to the Cook Pharmica acquisition which contributed 21% to the segment’s revenue growth in the reported quarter. The segment’s EBITDA soared 62% to $81.1 million compared to $50.0 million in Q2 FY17, driven in part by the acquisition of Cook Pharmica.

Catalent’s Clinical Supply Services segment’s revenues were $108.7 million for Q2 FY18, reflecting an increase of 41% on an as reported basis, or 36% in constant currency, versus $77.0 million in Q2 FY17, driven by higher volumes related to core storage and distribution services, as well as due to increased lower-margin comparator sourcing activities. The segment’s EBITDA was $19.0 million in Q2 FY18, up 64% compared to $11.6 million in the prior year’s same quarter. The segment’s backlog was $306.0 million as of December 31, 2017, an 8% decrease compared to Q1 FY18. The segment also recorded net new business wins of $80.0 million during the reported quarter, which represented a 26% drop on a y-o-y basis. The segment’s trailing-twelve-month book-to-bill ratio was 0.9.

New CFO

Catalent announced the appointment of senior executive Wetteny Joseph as its Senior Vice President and CFO, effective February 06, 2018, succeeding Matt Walsh, who has announced his desire to leave the Company to assume the position of CFO of Allergan Plc.

Joseph has over 20 years of managerial, finance, accounting, and strategic experience, most recently as the President of Catalent’s Clinical Supply Services business unit. He joined the Company in 2008 as its Vice President and Corporate Controller, and held senior finance positions through 2015, when he was chosen to lead the Clinical Supply Services segment.

Balance Sheet and Liquidity

As of December 31, 2017, Catalent had $2.7 billion in total debt, and $2.4 billion in total debt net of cash and short-term investments. As of December 31, 2017, Catalent’s total net leverage ratio was 4.8x.

On October 18, 2017, Catalent issued $450 million aggregate principal amount of 4.875% senior unsecured notes due January 2026. The net proceeds of these notes were used, along with cash on hand and the net proceeds of a primary offering of the Company’s common stock, to fund the $750 million, and a previous deposit, due at the closing of the Cook Pharmica acquisition.

Stock Performance Snapshot

February 26, 2018 – At Monday’s closing bell, Catalent’s stock slightly advanced 0.19%, ending the trading session at $42.92.

Volume traded for the day: 402.67 thousand shares.

Stock performance in the last three-month – up 10.28%; previous six-month period – up 21.90%; past twelve-month period – up 51.39%; and year-to-date – up 4.48%

After yesterday’s close, Catalent’s market cap was at $5.71 billion.

Price to Earnings (P/E) ratio was at 47.64.

The stock is part of the Healthcare sector, categorized under the Drugs – Generic industry. This sector was up 1.0% at the end of the session.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com
Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 490847

Stock Monitor: Stepan Post Earnings Reporting

LONDON, UK / ACCESSWIRE / February 27, 2018 / Active-Investors.com has just released a free earnings report on Church & Dwight Co., Inc. (NYSE: CHD). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=CHD. Church & Dwight reported its fourth quarter fiscal 2017 operating and financial results on February 05, 2018. The maker of household and personal products outperformed top- and bottom-line expectations and provided guidance for the upcoming quarter and fiscal year. Register today and get access to over 1,000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is currently working on the research report for Stepan Company (NYSE: SCL), which also belongs to the Consumer Goods sector as the Company Church & Dwight. Do not miss out and become a member today for free to access this upcoming report at:

www.active-investors.com/registration-sg/?symbol=SCL

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Church & Dwight most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=CHD

Earnings Highlights and Summary

For Q4 2017, Church & Dwight’s reported net sales jumped 15.3% to $1.03 billion compared to $896.0 million in Q4 2016. The Company’s reported quarter organic sales growth was 3.4%, driven by volume growth of 4.3%. Church & Dwight’s reported numbers exceeded analysts’ estimates of $1.01 billion.

During Q4 2017, Church & Dwight’s gross margin increased 110 basis points to 46.6%. Excluding the charge related to the sale of the Brazilian Specialty Products business, the Company’s reported quarter adjusted gross margin increased 50 basis points, primarily driven by productivity programs, volume and the positive impact of acquisitions and divestitures.

For Q4 2017, Church & Dwight’s marketing expense was $120.6 million, reflecting an increase of 3.7% on a y-o-y basis. The Company’s marketing expense as a percentage of net sales decreased 130 basis points to 11.7% as spending had been shifted to earlier quarters.

Church & Dwight’s reported net income totaled $405.6 million, or $1.60 per share, compared to $110.4 million, or $0.42 per diluted share, in Q4 2016. Excluding the one-time tax benefit of $272.9 million, or $1.06 per share, to adjust deferred tax accounts and reflect deemed repatriation of foreign subsidiary earnings as a result of the Tax Cuts and Jobs Act (TCJA), the Company’s adjusted earnings advanced 18% to $0.52 per share, ahead of Wall Street’s estimates of $0.50 per share.

For full year (FY) 2017, Church & Dwight reported revenues of $3.78 billion, compared to $3.49 billion in FY16.

The Company’s earnings totaled $743.7 million, or $2.90 per share, in FY17 compared to $459.0 million or $1.75 per diluted share in FY16. The Company’s adjusted earnings jumped 10% from $1.77 to $1.94 per share in FY17. For FY17, Church & Dwight’s adjusted earnings excluded one-time tax benefit of $272.9 million, or $1.06 per share, as a result of TCJA, a charge related to the sale of the Brazilian Specialty Products business, a U.K. pension settlement charge of $0.12 and a tax benefit $0.03 from a prior year joint venture impairment charge.

Church & Dwight’s Segment Results

During Q4 2017, the Consumer Domestic segment’s net sales jumped 13.3% to $787.8 million on a y-o-y basis. The segment’s organic sales increased 2.7% due to higher volume, partially offset by price. Volume growth was driven by key new product launches and personal care sales growth.

For Q4 2017, the Consumer International segment surged 33.3% to $170.1 million driven by recent acquisitions and broad-based household and personal care sales growth. Organic sales increased 5.8% due to higher volume, partially offset by price.

The Specialty Products segment’s net sales grew 3.0% to $75.2 million in Q4 2017. The segment’s organic sales increased 5.1% due to higher volume and commodity pass-through pricing primarily in the animal productivity business.

Operating Cash Flow

For FY17, Church & Dwight’s net cash from operating activities was $681.5 million compared to $655.3 million in FY16 due to higher cash earnings partially offset by an increase in working capital. At December 31, 2017, Church & Dwight’s cash on hand was $278.9 million, while total debt was $2.37 billion.

Outlook for 2018

For FY18, Church & Dwight is forecasting earnings in the range of $2.24 to $2.28 per share, or adjusted earnings growth of 16%-18%. The Company is estimating sales growth of approximately 8% and organic sales growth of approximately 3%.

For Q1 2018, Church & Dwight is forecasting sales growth of approximately 11% and organic sales growth of approximately 2%. The Company is estimating earnings of $0.61 per share, a 19.6% reported increase over Q1 2017 earnings and a 17.3% adjusted increase over the prior year’s same quarter earnings.

Stock Performance Snapshot

February 26, 2018 – At Monday’s closing bell, Church & Dwight’s stock climbed 1.77%, ending the trading session at $49.99.

Volume traded for the day: 2.19 million shares, which was above the 3-month average volume of 2.17 million shares.

Stock performance in the last month – up 1.32%; previous three-month period – up 11.68%; past six-month period – up 0.79%; and previous twelve-month period 0.93%

After yesterday’s close, Church & Dwight’s market cap was at $12.48 billion.

Price to Earnings (P/E) ratio was at 27.21.

The stock has a dividend yield of 1.74%.

The stock is part of the Consumer Goods sector, categorized under the Cleaning Products industry. This sector was up 1.1% at the end of the session.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com
Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 490848

CPR Provides Fast, Affordable Repairs for Phones, Tablets, Laptops and Game Consoles

INDEPENDENCE, OH / ACCESSWIRE / February 27, 2018 / CPR Cell Phone Repair, North America’s largest device repair retail chain, has reached an agreement to acquire the Digital Doc Franchise system. Digital Doc currently operates 37 locations throughout the US.

Established in 2010, Digital Doc is a leading provider of certified, pre-owned devices and a premier destination for cell phone, tablet and computer repairs. Armed with a team of trained and certified staff members, each Digital Doc location serves as a one-stop-shop for customers looking to address their technology needs in an efficient and reliable manner.

“We have tremendous respect for what the team at Digital Doc has built and are thrilled to announce that CPR is acquiring Digital Doc,” said Josh Sevick, CEO of CPR. “Acquiring another leading tech repair company was a no-brainer for us, particularly because our goals and core values align so closely with those of the Digital Doc management team. I would also like to take this opportunity to publicly welcome the Digital Doc franchise owners to the CPR family. We couldn’t be more excited to be partnering with you.”

Digital Doc President Levi Dinkla shares Sevick’s enthusiasm. “The top priority for everyone here at Digital Doc was doing what is good for our franchisees,” explained Dinkla. “We feel that being part of a national store network is going to be increasingly critical to success in the device repair industry. CPR has the largest store network of any company in the industry, a very similar business model to Digital Doc, minimal footprint overlap with existing Digital Doc locations and, most importantly, a leadership team we trust. For these reasons, we are confident that this acquisition with CPR is the best thing for our franchisees.”

“The addition of Digital Doc provides us with a nice lift towards our goal of having 600 stores operating by the end of 2018,” said Steve Ritley, VP of Franchise Operations. Steve went on to say that Digital Doc franchisees should benefit significantly from the marketing, training, and supply chain offerings that CPR provides to its franchisees.

The CPR / Digital Doc acquisition is just the latest in a series of events that strongly suggest the device repair industry will mature and institutionalize. Although the space is still highly fragmented and is comprised largely of independent, mom-and-pop repair shops, some consolidation has begun, and it is expected to accelerate in the coming months. Of the consolidation, Josh Sevick said, “We continue to be impressed by the quality of the independent store and regional chain operators that we meet from all over the country. Some of them have chosen to join CPR, which we see as strong validation of what we are doing. We will continue to actively recruit talented repair industry operators to partner with us in new markets.”

In addition to converting Digital Doc stores to the CPR brand, the CPR team will continue to focus on aggressively growing its store network and on strengthening key strategic alliances that will help the company continue to thrive as the repair industry matures.

About CPR Cell Phone Repair:

Founded in Orlando, Fla. in 1996, CPR Cell Phone Repair is the fastest growing wireless technology franchise in North America and operates over 400 locations internationally. As a pioneer and leader in the electronics repair industry, CPR offers same-day repair and refurbishing services for cell phones, laptops, gaming systems, digital music players, tablets and other personal electronic devices. For three straight years CPR was named in Entrepreneur Magazine’s Franchise 500 List. In 2018 CPR was ranked in the top 30 of the list. For more information about CPR Cell Phone Repair and franchise opportunities, visit http://www.cellphonerepair.com/ or call 877-856-5101.

Contact:

Stephen Ritley
sritley@merrymtg.com
216-674-0645 x632

SOURCE: CPR Cell Phone Repair

ReleaseID: 490872

NEW YORK, NY / ACCESSWIRE / February 27, 2018 / Latest key findings by Growth Market Report for all traders, shareholders, and investors of GrowGeneration Corp. (OTCQX: GRWG) and Pazoo, Inc. (OTC PINK: PZOO), including recent technical analysis and consolidated fundamental information.

Growth Market Report Initiates Coverage on:

GRWG DOWNLOAD: http://GrowthMarketReport.com/signup/?co=GRWG
PZOO DOWNLOAD: http://GrowthMarketReport.com/signup/?co=PZOO

GrowGeneration Corp. (GRWG) REPORT OVERVIEW

On February 23rd, 2018, GrowGeneration Corp. closed out the trading session at $4.51 (down 9.44%), compared to the previous day close of $4.98. The volume on the day was 293,257 (up 221.26%), compared to the company’s previous day volume of 91,284. For the twelve months ended December 31st, 2016 vs December 31st, 2015, GrowGeneration reported revenue of $7.98MM vs $3.46MM (up 130.98%) and basic earnings per share -$0.05 vs -$0.08.

Access Growth Market Report’s GrowGeneration Corp. Research Report at:
http://GrowthMarketReport.com/signup/?co=GRWG

Pazoo, Inc. (PZOO) REPORT OVERVIEW

On February 23rd, 2018, Pazoo, Inc. closed out the trading session at $0.0005 (down 54.55%), compared to the previous day close of $0.0011. The volume on the day was 956,666,880 (up 22.91%), compared to the company’s previous day volume of 778,337,664. For the twelve months ended December 31st, 2016 vs December 31st, 2015, Pazoo reported revenue of $0.03MM vs $0.03MM (up 14.23%) and basic earnings per share -$2.50 vs -$172.50.

Access Growth Market Report’s Pazoo, Inc. Research Report at:
http://GrowthMarketReport.com/signup/?co=PZOO

Our Actionable Research on GrowGeneration Corp. (OTCQX: GRWG) and Pazoo, Inc. (OTC PINK: PZOO) can be downloaded free of charge at http://GrowthMarketReport.com/.

ABOUT Growth Market Report

It’s no secret that Wall Street analysts spend the lion’s share of their time focused on large, well-known companies and securities – they make most of their money from investment banking. As a result, small cap companies are relatively underserved when it comes to top-quality research and analysis. Growth Market Report was developed to fill in that gap.

DISCLAIMER

Growth Market Report is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at
http://GrowthMarketReport.com/.

PRESS RELEASE PROCEDURES

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by Growth Market Report. Growth Market Report is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

Growth Market Report, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. Growth Market Report, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, Growth Market Report, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither Growth Market Report nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever.

MEDIA CONTACT:

Jack Sutherland, Media Department
Office: +1 (205) 217-4026
E-mail: media@GrowthMarketReport.com

SOURCE: Growth Market Report

ReleaseID: 490792

NEW YORK, NY / ACCESSWIRE / February 27, 2018 / Latest key findings by Growth Market Report for all traders, shareholders, and investors of Liquidmetal Technologies, Inc. (OTCQB: LQMT) and Cadus Corp. (OTCQB: KDUS), including recent technical analysis and consolidated fundamental information.

Growth Market Report Initiates Coverage on:

LQMT DOWNLOAD: http://GrowthMarketReport.com/signup/?co=LQMT
KDUS DOWNLOAD: http://GrowthMarketReport.com/signup/?co=KDUS

Liquidmetal Technologies, Inc. (LQMT) REPORT OVERVIEW

On February 23rd, 2018, Liquidmetal Technologies, Inc. closed out the trading session at $0.25 (up 6.43%), compared to the previous day close of $0.23. The volume on the day was 4,287,494 (up 790.16%), compared to the company’s previous day volume of 481,656. For the twelve months ended December 31st, 2016 vs December 31st, 2015, Liquidmetal Technologies reported revenue of $0.48MM vs $0.13MM (up 284.00%) and basic earnings per share -$0.03 vs -$0.02. Liquidmetal Technologies is expected to report earnings on March 9th, 2018, the report will be for the fiscal period ending December 31st, 2017.

Access Growth Market Report’s Liquidmetal Technologies Inc. Research Report at:
http://GrowthMarketReport.com/signup/?co=LQMT

Cadus Corp. (KDUS) REPORT OVERVIEW

On February 23rd, 2018, Cadus Corp. closed out the trading session at $1.59 (unchanged), compared to the previous day close of $1.59. The volume on the day was 375,759 (up 95.96%), compared to the company’s previous day volume of 191,751. Cadus is expected to report earnings on March 30th, 2018, the report will be for the fiscal period ending December 31st, 2017.

Access Growth Market Report’s Cadus Corp. Research Report at:
http://GrowthMarketReport.com/signup/?co=KDUS

Our Actionable Research on Liquidmetal Technologies Inc. (OTCQB: LQMT) and Cadus Corp. (OTCQB: KDUS) can be downloaded free of charge at http://GrowthMarketReport.com/.

ABOUT Growth Market Report

It’s no secret that Wall Street analysts spend the lion’s share of their time focused on large, well-known companies and securities – they make most of their money from investment banking. As a result, small cap companies are relatively underserved when it comes to top-quality research and analysis. Growth Market Report was developed to fill in that gap.

DISCLAIMER

Growth Market Report is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at http://GrowthMarketReport.com/.

PRESS RELEASE PROCEDURES

The non-sponsored content contained herein has been prepared by a writer (the ”Author”) and is fact checked and reviewed by a third party research service company (the ”Reviewer”) represented by a credentialed financial analyst, provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by Growth Market Report. Growth Market Report is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

Growth Market Report, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. Growth Market Report, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, Growth Market Report, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither Growth Market Report nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever.

MEDIA CONTACT:

Jack Sutherland, Media Department
Office: +1 (205) 217-4026
E-mail: media@GrowthMarketReport.com

SOURCE: Growth Market Report

ReleaseID: 490795

CPR Provides Fast, Affordable Repairs for Phones, Tablets, Laptops and Game Consoles

INDEPENDENCE, OH / ACCESSWIRE / February 27, 2018 / CPR Cell Phone Repair, the largest and fastest growing mobile device repair franchise network in North America, is pleased to announce the opening of a new store in Atlanta, GA. The CPR network applauds owner Wade Bailey on this achievement and welcomes him to the CPR team.

To learn more about CPR Cell Phone Repair Atlanta – Druid Hills, please visit: https://www.cellphonerepair.com/atlanta-druid-hills-ga.

“With Wade’s genuine passion for technology and many years of experience in the audio visual industry, we know he has what it takes to operate a successful CPR Cell Phone Repair shop,” says Josh Sevick, CEO of CPR. “Our franchise network is lucky to have him on our team.”

CPR Atlanta – Druid Hills is in a vibrant scene in the North Druid Hills area and is just a short distance from Interstate 85 and Emory University. The store is located at the corner of Briarcliff Rd and North Druid Hills Rd next to Sublime Doughnuts.

“I am excited for the opportunity to bring top-notch tech repair to the Atlanta community. Our focus is not only on providing high-quality, affordable repairs, but also on building relationships with and providing assurance to the people we serve,” says Bailey. “We want our customers to have a great experience.”

Bailey is a member of the Dekalb Chamber of Commerce where he is involved in the business community. He has lived in Atlanta for nearly 20 years and is married to his wife of six years, with whom he shares two beautiful daughters. When Wade is not being a tech repair expert, he loves traveling or enjoying a craft beer from one of the many local breweries.

CPR Cell Phone Repair Atlanta – Druid Hills is located at:

2566 Briarcliff Rd NE Suite 108
Atlanta, GA 30329

Please contact the store at: 404-205-5115 or repairs@cpr-druidhillsga.com.

Please visit the website: https://www.cellphonerepair.com/atlanta-druid-hills-ga.

About CPR Cell Phone Repair:

Founded in Orlando, Fla. in 1996, CPR Cell Phone Repair is the fastest growing wireless technology franchise in North America and operates over 400 locations internationally. As a pioneer and leader in the electronics repair industry, CPR offers same-day repair and refurbishing services for cell phones, laptops, gaming systems, digital music players, tablets and other personal electronic devices. For three straight years CPR was named in Entrepreneur Magazine’s Franchise 500 List. In 2018 CPR was ranked in the top 30 of the list. For more information about CPR Cell Phone Repair and franchise opportunities, visit http://www.cellphonerepair.com/ or call 877-856-5101.

Contact:

Stephen Ritley
sritley@merrymtg.com
216-674-0645 ext. 632

SOURCE: CPR Cell Phone Repair

ReleaseID: 490871

Stock Monitor: CVR Energy Post Earnings Reporting

LONDON, UK / ACCESSWIRE / February 27, 2018 / Active-Investors.com has just released a free research report on Valero Energy Corp. (NYSE: VLO) (“Valero”). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=VLO as the Company’s latest news hit the wire. On February 24, 2018, the Company announced that its subsidiary, Valero Logistics UK Ltd, has inked an agreement to acquire SemLogistics Milford Haven (“SemLogistics”)’s fuel storage facility on the west coast of Wales, United Kingdom, from SemGroup Corp. The financial details of the agreement remains undisclosed. Register today and get access to over 1000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is currently working on the research report for CVR Energy, Inc. (NYSE: CVI), which also belongs to the Basic Materials sector as the Company Valero Energy. Do not miss out and become a member today for free to access this upcoming report at:

www.active-investors.com/registration-sg/?symbol=CVI

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Valero Energy most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=VLO

Details of the Deal

As per the agreement terms, in addition to the sales price, Valero is required to make potential earn-out payments to SemGroup if certain revenue targets are met in the four years following the close of the transaction. SemGroup intends to use the proceeds from the sale toward its capital raise plan and to pre-fund capital growth projects.
The transaction, expected to close in the third quarter of 2018, is subject to certain customary conditions and regulatory approvals. Valero will retain the UK employees currently engaged in the business to be acquired.
Over 67% of the storage capacity is multiproduct or dual purpose, giving Valero the flexibility to meet customers’ demands in the UK and throughout Northwest Europe. Additionally, SemLogistics will continue to operate as a third-party storage facility, offering storage options for third party customers across the European petroleum markets.

The Facility Complements Valero’s Pembroke Refinery and Fuel Terminal in the UK and Ireland

Joe Gorder, Chairman, President, and Chief Executive Officer (CEO) of Valero, stated that this facility complements the Company’s Pembroke refinery and fuel terminal in the UK and Ireland, making it a natural fit for Valero. Gorder added that this purchase demonstrates Valero’s commitment to Wales and the UK, and it aligns with its strategy to grow the logistics business and reduce secondary costs.

SemLogistics’s Fuel Storage Facility

Situated across the Haven from Valero’s refinery at Pembroke, the facility is one of the largest petroleum products storage facility in the UK with 8.5 million barrels of capacity for storing gasoline, gasoline blend-stocks, naphtha, jet fuel, gas oil, diesel, and crude oil.

Valero Announced Additional Share Repurchase Authorization

On January 23, 2018, Valero’s Board of Directors approved an incremental $2.5 billion share repurchase authorization. The Company has approximately $1.2 billion of repurchase authority available under its previously announced buyback authorization, giving it $3.7 billion available for stock repurchases going forward. The Board also approved an increase in the Company’s regular quarterly cash dividend on common stock from $0.70 per share to $0.80 per share, effective with the quarterly dividend that the Board has declared to be payable on March 06, 2018, to holders of record at the close of business as on February 13, 2018.

About Valero Energy Corp.

Founded in 1980 and based in San Antonio, Texas, Valero, through its subsidiaries, is an international manufacturer and marketer of transportation fuels and other petrochemical products. The Company is an independent petroleum refiner and ethanol producer. The petroleum refineries are located in the United States, Canada, and the United Kingdom, and the ethanol plants are in the Mid-Continent region of the US.

About SemGroup Corp.

Based in Tulsa, Oklahoma, SemGroup is a publicly-traded midstream service Company providing the energy industry the means to move products from the wellhead to the wholesale marketplace. The Company provides diversified services for end-users and consumers of crude oil, natural gas, natural gas liquids, refined products, residual fuel oil, and asphalt.

Stock Performance Snapshot

February 26, 2018 – At Monday’s closing bell, Valero Energy’s stock slightly rose 0.92%, ending the trading session at $93.31.

Volume traded for the day: 2.56 million shares.

Stock performance in the last three-month – up 13.31%; previous six-month period – up 28.36%; past twelve-month period – up 39.85%; and year-to-date – up 1.52%

After yesterday’s close, Valero Energy’s market cap was at $40.96 billion.

Price to Earnings (P/E) ratio was at 20.25.

The stock has a dividend yield of 3.43%.

The stock is part of the Basic Materials sector, categorized under the Oil & Gas Refining & Marketing industry. This sector was up 0.7% at the end of the session.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com
Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 490840

Stock Monitor: Interface Post Earnings Reporting

LONDON, UK / ACCESSWIRE / February 27, 2018 / Active-Investors.com has just released a free earnings report on Albany International Corp. (NYSE: AIN) (“Albany”). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=AIN. The Company reported its financial results on February 05, 2018, for the fourth quarter and for the full year ended December 31, 2017. The Company showed a strong performance in Q4 FY17, with improvements in both its segments. Albany also reported a solid growth in total sales, adjusted EBITDA, and a strong cash flow. Register today and get access to over 1000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is currently working on the research report for Interface, Inc. (NASDAQ: TILE), which also belongs to the Industrial Goods sector as the Company Albany Intl. Do not miss out and become a member today for free to access this upcoming report at:

www.active-investors.com/registration-sg/?symbol=TILE

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Albany International most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=AIN

Earnings Highlights and Summary

For the fourth quarter of the fiscal year 2017, Albany’s total revenues reached $226.73 million, up 6.42% from $213.05 million in Q4 FY16. The y-o-y percentage increment in sales, excluding the impact of $5.32 million from changes in currency translation rates, was 3.9%. The Company’s revenue numbers exceeded analysts’ consensus estimates of $218.3 million.

During Q4 FY17, Albany’s gross profit was $77.39 million compared to $77.33 million in Q4 FY16. The Company’s gross profit margin dipped 2.17% to 34.13% in the reported quarter from 36.3% in Q4 FY16, due to higher than normal end-of-year underutilization of capacity. The Company’s operating income also declined 15.9% to $22.56 million in Q4 FY17 from $26.83 million in Q4 FY16. Albany’s operating margin was 9.95% for the reported quarter compared to 12.59% in the same period of last year.

Albany’s net income attributable to common shareholders was $5.89 million in Q4 FY17, a decrease of 62.74% from $15.80 million in Q4 FY16. The Company’s diluted earnings per share (EPS) attributable to common shareholders were $0.18 in the quarter under review, 63.27% lower than the $0.49 recorded in the comparable period of last year.

For Q4 FY17, Albany’s reported earnings included a net charge of $5.1 million, or $0.16 per share, for income tax adjustments, resulting primarily from changes in US tax laws, charges of $3.3 million in restructuring, and losses of $1.8 million from foreign currency revaluation.

Albany’s adjusted EPS attributable to common shareholders, excluding non-recurring and non-core items, were $0.44 in Q4 FY17 compared to $0.36 in Q4 FY16, reflecting an increase of 22.22%. The Company’s reported adjusted EPS were higher than analysts’ consensus estimates of $0.42.

For the year ending December 31, 2017, Albany’s total revenues were $863.72 million, up 10.76% from $779.84 million in FY16. The y-o-y percentage increment in sales, excluding the impact of $3.75 million from changes in currency translation rates, was 10.3%.

Albany’s net income attributable to common shareholders decreased 37.21% to $33.11 million in FY17 from $52.73 million in FY16. The Company’s diluted EPS attributable to common shareholders also declined 37.20% to $1.03 in the year under review from $1.64 in the previous year. The Company’s diluted EPS, excluding special items, were $1.67 in FY17, 5.65% lower than $1.77 in FY16.

Segment Details

During Q4 2017, Albany’s Machine Clothing (MC) segment’s net revenues were $150.26 million, up almost 3.81% y-o-y. The continuing declines in the publication grades were more than offset by a growth in other grades. Of this, an increment of $4.38 million in revenues was due to the impact of changes in currency translation rates. The MC segment’s operating income was $34.58 million for the quarter ending December 31, 2017, compared to $39.95 million for the corresponding period of last year, reflecting a decrease of 13.42%. The segment’s operating margin declined 4.58% to 23.02% in Q4 FY17 from 27.6% in Q4 FY16.

For Q4 FY17, Albany’s Engineered Composites (AEC) segment’s net revenues advanced 11.95% to $76.47 million on a y-o-y basis, led by a growth in the 787 fuselage frames, F-35 airframe, and CH-53K programs. Of this, an increment of $0.94 million in revenues was due to the impact of changes in currency translation rates. In the reported quarter, the segment’s operating income was $0.585 million, up 145.70% from an operating loss of $1.28 million in Q4 FY16.

Cash Matters

Albany had cash and cash equivalents of $183.73 million as on December 31, 2017, 1.09% higher than $181.74 million as on December 31, 2016. The Company’s long-term debt was $516.18 million as on December 31, 2017, compared to $484.90 million as on December 31, 2016.

During Q4 FY17, the Company’s net cash flow from operating activities was $40.00 million, up 44.28% from $27.73 million in Q4 FY16, owing to a good operating performance and management of working capital. The Company’s capital expenditure was $22.87 million in Q4 2017 compared to $22.20 million in Q4 2016.

For the quarter ended December 31, 2017, the Company paid dividends of $5.47 million, almost in-line with the $5.46 million distributed in Q4 FY16.

Outlook

For the full fiscal year 2018, Albany expects sales to be up by 20% to 30%, led by ramp-ups in LEAP, 787 fuselage frames, and F-35 programs. Albany expects a steady incremental improvement in adjusted EBITDA as a percentage of sales, holding revenue recognition standards constant. Albany expects a robust order backlog, healthy economic conditions, and a continued strong product performance to drive growth in FY18.

Stock Performance Snapshot

February 26, 2018 – At Monday’s closing bell, Albany International’s stock was slightly up 0.30%, ending the trading session at $66.45.

Volume traded for the day: 103.72 thousand shares.

Stock performance in the last month – up 5.31%; previous three-month period – up 5.23%; past twelve-month period – up 40.34%; and year-to-date – up 8.14%

After yesterday’s close, Albany International’s market cap was at $2.16 billion.

Price to Earnings (P/E) ratio was at 56.65.

The stock has a dividend yield of 1.02%.

The stock is part of the Industrial Goods sector, categorized under the Textile Industrial industry. This sector was up 1.0% at the end of the session.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com
Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 490842